1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Covestro AG
  6. News
  7. Summary
    1COV   DE0006062144


Real-time Estimate Tradegate  -  03:59 2022-08-19 pm EDT
31.61 EUR   -0.77%
08/15COVESTRO : Receives a Buy rating from Jefferies
08/15COVESTRO : Gets a Neutral rating from UBS
08/09COVESTRO : Berenberg reiterates its Neutral rating
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

DSM forges nutrition and fragrance giant with Firmenich deal

05/31/2022 | 01:54am EDT
DSM logo is seen at the headquarters in Heerlen

* DSM to take over Firmenich in cash and share deal

* Merger will vie with IFF in nutrition sector

* DSM selling engineering plastics unit to Lanxess

* DSM shares jump 8.2%; Lanxess shares rise more than 11%

AMSTERDAM, May 31 (Reuters) - Dutch specialty chemicals maker DSM struck deals to take over Swiss flavor and fragrance maker Firmenich and sell its engineering plastics division to become a major player in the fast-growing food ingredients and health products markets.

Shares in DSM jumped as much as 12.6% after the company said on Tuesday that its shareholders will take 65.5% of the shares in a new group called DSM-Firmenich, while the owners of unlisted Firmenich will receive a 34.5% stake of the combined entity plus 3.5 billion euros in cash from DSM.

Analysts at brokerage Stifel said the transaction would "create a new giant in the nutrition space, and the only one to combine flavors and fragrances with nutritional benefits."

Firmenich's businesses include making food ingredients and scents for detergents and creating fragrances for brands such as Calvin Klein and Mugler.

At about 11.4 billion euros ($12.3 billion) in combined 2021 revenue, the new player will contest IFF Inc's leadership in the market for fragrances, flavors and ingredients for food and cosmetics. IFF, which last year combined with DuPont’s Nutrition and Biosciences business, had $11.7 billion in 2021 sales.

In a back-to-back deal that concludes DSM's exit from industrial materials, DSM also agreed to sell its engineering plastics division to German peer Lanxess and private-equity firm Advent for 3.85 billion euros including assumed debt.

Stifel analysts said the Firmenich deal values the Swiss company at 19.2 billion euros including debt, based on DSM's closing price on Monday. Also based on that price, DSM said its contribution to the merged entity had an implied value of 21.6 billion. It would not provide an overall valuation.

But the nominal price tag for the combined group, working out at close to 41 billion euros, was marked up heavily on Tuesday, with DSM shares last up 8.2%, giving up some initial gains. Shares in Lanxess jumped more than 11% to a two-month high. The two stocks were Europe's top performing shares on Tuesday.

"We're bringing together two iconic companies, where DSM is strong in health and nutrition, and Firmenich is very strong in fragrances and taste," said DSM co-Chief Executive Dimitri de Vreeze.

"That creates solutions where we have health, sustainability, and tastes and flavor as being key for the future," he added.

Firmenich's owners would become long-term shareholders of DSM-Firmenich, the two companies said, describing the transaction as a "merger of equals."

DSM's board Chairman Thomas Leysen and DSM's co-CEOs Geraldine Matchett and Dimitri de Vreeze will take on the same roles at the merged group.

Firmenich Chairman Patrick Firmenich, from the fourth generation of the founding family, is to become vice chairman, and the family is set to become the largest shareholder group in the new entity.

Givaudan and Symrise are the runner-ups in the market share ranking for fragrances, flavors and ingredients for food and cosmetics. The industry, which has been expanding into functional food and health ingredients, offers strong growth, driven by consumers in emerging markets, with few cyclical swings.

DSM and Firmenich said the merged group, expected to be created in the first half of next year, could see organic sales growth of 5% to 7% per year, while realizing annual synergies from cost savings and new revenue opportunities of 350 million euros.

DSM said last September that it would focus purely on ingredients for food and health products, having sold a unit making resins and coatings to Germany's Covestro https://www.covestro.com/press/covestro-successfully-completes-acquisition-of-resins--functional-materials-business-from-dsm for about 1.6 billion euros earlier in the year.

DSM last month agreed to sell its protective materials business, part of the materials division, to Avient Corp for $1.48 billion.

Sales of its nutrition division, which produces goods ranging from vitamins and other supplements to baby formula and animal feed, rose 10% to 7 billion euros last year. DSM's total sales were 9.2 billion euros in 2021.

Firmenich reported sales of 4.5 billion Swiss franc ($4.7 billion) last year. Both companies realized an adjusted core profit margin (EBITDA) of around 20%.


The new company will have dual headquarters in Kaiseraugst near Basel, Switzerland, and in the Dutch city of Maastricht. Its legal domicile will be in Switzerland but the shares will be listed on the Euronext Amsterdam exchange.

The merger will be effected through a public offer of DSM shares, in which current DSM shareholders can exchange their share for a share in the new company.

Lanxess and Advent said in a separate statement they formed a joint venture to acquire DSM's Engineering Materials business, a maker of plastics mainly for car parts, for 3.7 billion euros including assumed debt.

Lanxess will transfer its own engineering plastics business into the new venture, receiving a stake of up to 40% and a cash payment of at least 1.1 billion euros in return.

Under a drive to become less dependent on the cyclical auto industry, Lanxess secured an option to sell its stake to Advent after three years. ($1 = 0.9325 euros) (Reporting by Ludwig Burger in Frankfurt, Bart Meijer and Toby Sterling in Amsterdam, Emma-Victoria Farr in London, Patricia Weiss in Frankfurt, Mike Shields in Zurich; Editing by Kim Coghill and Susan Fenton)

© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
COVESTRO AG -1.16% 31.48 Delayed Quote.-41.24%
GIVAUDAN SA -1.20% 3298 Delayed Quote.-30.34%
LANXESS AG -2.43% 34.18 Delayed Quote.-35.72%
ROYAL DSM N.V. -0.56% 142.8 Real-time Quote.-27.47%
SYMRISE AG -0.96% 112.9 Delayed Quote.-12.51%
All news about COVESTRO AG
08/15COVESTRO : Receives a Buy rating from Jefferies
08/15COVESTRO : Gets a Neutral rating from UBS
08/09COVESTRO : Berenberg reiterates its Neutral rating
08/08Stratasys Agrees to Acquire Covestro's Additive Manufacturing Materials Business for $4..
08/08Covestro To Sell Additive Manufacturing Business Unit To Stratasys
08/08COVESTRO : announces sale of Additive Manufacturing Business to Stratasys
08/05COVESTRO : Barclays reaffirms its Buy rating
08/05COVESTRO : Raised to Buy by Jefferies
08/03European Natural Gas Prices Rise as Nord Stream Gas Flows Fluctuate Lower, ANZ Bank Say..
08/03COVESTRO : JP Morgan remains Neutral
More news
Analyst Recommendations on COVESTRO AG
More recommendations
Sales 2022 18 027 M 18 099 M 18 099 M
Net income 2022 658 M 660 M 660 M
Net Debt 2022 2 641 M 2 651 M 2 651 M
P/E ratio 2022 8,78x
Yield 2022 6,35%
Capitalization 6 015 M 6 039 M 6 039 M
EV / Sales 2022 0,48x
EV / Sales 2023 0,52x
Nbr of Employees 17 909
Free-Float 95,2%
Duration : Period :
Covestro AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COVESTRO AG
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 31,85 €
Average target price 46,21 €
Spread / Average Target 45,1%
EPS Revisions
Managers and Directors
Markus Steilemann Chief Executive Officer
Thomas Toepfer Chief Financial Officer & Labor Director
Richard Pott Chairman-Supervisory Board
Klaus Schäfer Chief Technology Officer
Petra Kronen Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
COVESTRO AG-41.24%6 169
DOW INC.-1.23%40 232
LG CHEM, LTD.4.07%36 306